App ist vorübergehend nicht verfügbar

HEART Pathway

Chest pain. Risk-stratified.

Veröffentlicht von: Unknown

Beschreibung

A validated clinical decision tool for patients presenting to the emergency department with chest pain, created by Wake Forest University School of Medicine physicians. For patients presenting with chest pain, the HEART Pathway algorithm has been shown to reduce patient length of stay by 12 hours, reduce cost by 14 percent per patient, and results in a MACE rate of < 1%.
If interested in licensing the HEART Pathway for use at your institution please contact us via our website.
HEART Pathway randomized controlled trial: http://www.ncbi.nlm.nih.gov/pubmed/25737484
Chest pain is a top cause of US ED visits. Eight to ten million patients with chest pain present to an ED annually in the United States. More than half of Emergency Department patients with chest pain receive lengthy cardiac evaluations in an chest pain unit or inpatient ward, with an annual cost $10-13 billion. Less than ten percent of patients have an acute coronary syndrome (ACS). Two to five percent of patients with myocardial infarctions are inappropriately discharged from the ED every year. Missed ACS is a top cause of malpractice claims.
What is the HEART Pathway?
The HEART Pathway is designed for more accurate cardiac risk stratification for patients presenting to the ER with Chest Pain. The HEART Pathway is similar to the HEART Score but has been modified by researchers at Wake Forest University School of Medicine.
The HEART Pathway has been validated by researchers at Wake Forest University School of Medicine and is used on a daily basis at Wake Forest and our affiliate emergency departments.
The HEART Pathway randomized controlled trial (Mahler et al, Circ CVQO J, 2015.) has demonstrated the benefits of the HEART Pathway compared with usual care. When HEART Pathway was applied to chest pain patients researchers found an increase in early discharge rate from 18% to 39% with a cost savings of over $200 per patient.
The HEART Pathway assists providers with answering the following questions:
Should I admit my patient for stress testing or can I discharge my patient from the Emergency Room?
What is the likelihood that my patient’s presenting symptoms represent ACS?
What is the likelihood that my patient will have an ACS event in the near future (within 30 days)?
Ausblenden Mehr anzeigen...

Screenshots

HEART Pathway Häufige Fragen

  • Ist HEART Pathway kostenlos?

    Ja, HEART Pathway ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist HEART Pathway seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet HEART Pathway?

    HEART Pathway ist kostenlos.

  • Wie hoch ist der Umsatz von HEART Pathway?

    Um geschätzte Einnahmen der HEART Pathway-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Malaysia noch nicht bewertet.
Bewertungsverlauf

HEART Pathway Bewertungen

App hat noch keine Bewertungen

HEART Pathway Konkurrenten

Name
CorePendium
The Crucial Clinical Reference
EM:RAP - Medical Education
Emergency Medicine & Beyond
MobilEM
Fast, evidence-based guidance
ACEP emPOC
EB Medicine
Emergency Medicine Education
palmEM AI: EM Quick Reference
Emergency Medicine with AI
EM Coach
EM Board Review
R.E.B.E.L. EM
ACEP Toxicology Section Antido
EasyTBSA

HEART Pathway Installationen

Letzte 30 Tage

HEART Pathway Umsatz

Letzte 30 Tage

HEART Pathway Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von HEART Pathway mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.